Category: Pharmacy - Page 2

How to Talk to Patients About Generic Medications: A Practical Guide for Providers 7 Jan 2026

How to Talk to Patients About Generic Medications: A Practical Guide for Providers

Learn how to effectively communicate with patients about generic medications to improve adherence, reduce costs, and build trust. Practical tips for providers on explaining bioequivalence, addressing concerns, and using proven communication frameworks.

View More
How Pharmacists Communicate Generic Recommendations to Prescribers 4 Jan 2026

How Pharmacists Communicate Generic Recommendations to Prescribers

Pharmacists play a key role in recommending generic drugs to prescribers to improve adherence and cut costs. Learn how they use the FDA Orange Book, navigate state laws, and communicate effectively to ensure safe, evidence-based substitutions.

View More
Crossover Trial Design: How Bioequivalence Studies Are Structured 31 Dec 2025

Crossover Trial Design: How Bioequivalence Studies Are Structured

Crossover trial designs are the gold standard for bioequivalence studies, using each participant as their own control to compare generic and brand-name drugs efficiently. Learn how 2×2 and replicate designs work, why washout periods matter, and how regulators determine if drugs are truly equivalent.

View More
Generic Drug User Fee Amendments: How GDUFA Laws Speed Up FDA Reviews 19 Dec 2025

Generic Drug User Fee Amendments: How GDUFA Laws Speed Up FDA Reviews

GDUFA lets the FDA collect fees from generic drug makers to speed up reviews, cut backlogs, and ensure safe, affordable medicines reach patients faster. Learn how the law works, who pays, and why it matters.

View More
Adverse Event Reporting: What Pharmacists Must Know About Generic Medication Safety 18 Dec 2025

Adverse Event Reporting: What Pharmacists Must Know About Generic Medication Safety

Pharmacists play a critical role in identifying and reporting adverse events from generic medications. Learn why reporting matters, how to do it correctly, and how your actions improve patient safety across the system.

View More
Cost Comparison: Authorized Generics vs First-to-File Generics in the U.S. Drug Market 17 Dec 2025

Cost Comparison: Authorized Generics vs First-to-File Generics in the U.S. Drug Market

Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down further by adding competition during the first 180 days of generic market entry. Learn how they differ and which saves you more.

View More
How to Identify Look-Alike Names on Prescription Labels 16 Dec 2025

How to Identify Look-Alike Names on Prescription Labels

Learn how to spot dangerous look-alike drug names on prescription labels using tall man lettering, barcode scanning, and simple verification steps. Reduce your risk of medication errors with practical, real-world tips.

View More
What Is an ANDA? The Complete Guide to Abbreviated New Drug Applications 12 Dec 2025

What Is an ANDA? The Complete Guide to Abbreviated New Drug Applications

An ANDA, or Abbreviated New Drug Application, is the FDA pathway that allows generic drugs to enter the market without repeating costly clinical trials. It saves billions annually and makes medications affordable for millions.

View More
Unexpected Side Effects from Generic Medications: When to Seek Help 10 Dec 2025

Unexpected Side Effects from Generic Medications: When to Seek Help

Generic medications save money but can trigger unexpected side effects due to differences in inactive ingredients. Learn which drugs carry the highest risk and when to seek medical help after a switch.

View More
Coenzyme Q10 and Blood Pressure Medications: What You Need to Know About Effectiveness and Risks 7 Dec 2025

Coenzyme Q10 and Blood Pressure Medications: What You Need to Know About Effectiveness and Risks

Coenzyme Q10 may help lower blood pressure slightly, but it can interact dangerously with medications like warfarin or ACE inhibitors. Learn how to use it safely with your current treatment plan.

View More